Innovative early screening for AD, Escort Malaysia's healthy future!
Category: Enterprise dynamics
Category: News Center
Category: Industry Information
Category: Image Center
2024-08-13
In an effort to revolutionize early screening for dementia in Malaysia, Hunan Qankorey, a leading health technology company, through its exclusive local distributor, has partnered with Sultan Abdul Aziz Shah Hospital (HSAAS) to conduct a clinical trial to introduce Malaysia's first One Step Dementia Risk Test Kit.
Left: Ng Lyp Hau, Director, Clotech Sdn Bhd
Right: Associate Professor Dr. Liyana Najwa Binti Inche Mat, Head of Department of Neurology, Faculty of Medicine at Universiti Putra Malaysia
These early screening reagents are expected to revolutionize the way dementia is diagnosed, enabling early screening and intervention, which is crucial for Malaysia's increasingly aging population. Currently, an estimated 8.5% to 11% of older people in Malaysia suffer from dementia.
The exclusive distributor and Sultan Abdul Aziz Shah Hospital formally signed a collaboration agreement (MOA) today in preparation for the research and application of the Alzheimer's early screening reagent in Malaysia.
The Alzheimer's disease early screening reagent has been approved by the Malaysian Medical Device Administration (MDA) and is expected to be provided to hospitals and clinics nationwide. The test provides a non-invasive method for early screening of mild cognitive impairment (MCI) and early-onset Alzheimer's disease by detecting amyloid in urine.
RELATED INFORMATION
Domestic business consulting:86-0731-85714218
Company E-mail:yingxiao@qankorey.com
International Business Consulting:86-18874232226
Company E-mail:lisa@qankorey.com
Company address: 12F, Building 15, 188 Middle Huanbao Road, Yuhua District, Changsha, Hunan , 410116, China
Production Address: 4th Floor, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha, Hunan , 410000, China
Public Number
Small program
Jingdong
Taobao